Pnc Financial Services Group, Inc. Alnylam Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 13,125 shares of ALNY stock, worth $4.05 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,125
Previous 12,540
4.67%
Holding current value
$4.05 Million
Previous $2.95 Million
20.14%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding ALNY
# of Institutions
720Shares Held
111MCall Options Held
978KPut Options Held
881K-
Capital World Investors Los Angeles, CA16.7MShares$5.17 Billion0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$4.03 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.95 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$2.21 Billion0.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.42MShares$1.36 Billion0.79% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $38B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...